Market Research Logo

Global Sepsis Diagnostics Market 2017-2021

Global Sepsis Diagnostics Market 2017-2021

About Sepsis Diagnostics

Sepsis is a three-staged syndrome; it starts with systemic infections leading to severe sepsis and ultimately causing sepsis shock, which is regarded as a medical emergency. Population with weak immune system, which include children, older adults, and people with chronic diseases such as cancer, AIDS, diabetes, are prone to sepsis.

Sepsis occurs mainly due to bacterial, viral, and fungal infections. Gram-negative bacilli such as E. coli, P. aeruginosa, E. corrodens, and Haemophilus influenzae (which occurs mainly in neonates) are the main agents that cause infection, leading to sepsis. Other bacteria which causes sepsis are S. aureus, Streptococcus species, Enterococcus species, and Neisseria species.

Technavio’s analysts forecast the global sepsis diagnostics market to grow at a CAGR of 6.74% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global sepsis diagnostics market for 2017-2021. To calculate the market size, the report considers the sales, volume and value of global sepsis diagnostics segment.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Sepsis Diagnostics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • bioMérieux
  • T2 Biosystems
Other prominent vendors
  • Alere
  • Abionic
  • AdvanDx
  • Aethlon Medical
  • AusDiagnostics
  • Beckman Coulter
  • Beckton Dickinson
  • Momentum Bioscience
  • Bio-Rad Laboratories
  • Bruker
  • Cepheid
  • Curetis
  • CytoSorbents
  • Fast Track Diagnostics
  • F. Hoffmann-La Roche
  • Fujirebio Europe
  • Hansa Medical
  • Hain Lifescience
  • Immunexpress
  • Inflammatix
  • Merck
  • miacom diagnostics
  • Mitsubishi Chemical Europe
  • Nanōmix
  • QIAGEN
  • Radiometer
  • Response Biomedical
  • Sepset Biosciences
  • Siemens Healthineers
  • TCS Biosciences
  • Thermo Fisher Scientific
Market driver
  • Rising prevalence of hospital acquired infection (HAIs) globally
  • For a full, detailed list, view our report
Market challenge
  • High cost of sepsis treatment
  • For a full, detailed list, view our report
Market trend
  • Increasing use of biomarkers for sepsis
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?


Press Release

Technavio Announces the Publication of its Research Report – Global Sepsis Diagnostics Market 2017-2021

Technavio recognizes the following companies as the key players in the global sepsis diagnostics market: bioMérieux and T2 Biosystems

Other Prominent Vendors in the market are: Alere, Abionic, AdvanDx, Aethlon Medical, AusDiagnostics, Beckman Coulter, Beckton Dickinson, Momentum Bioscience, Bio-Rad Laboratories, Bruker, Cepheid, Curetis, CytoSorbents, Fast Track Diagnostics, F. Hoffmann-La Roche, Fujirebio Europe, Hansa Medical, Hain Lifescience, Immunexpress, Inflammatix, Merck, miacom diagnostics, Mitsubishi Chemical Europe, Nanōmix, QIAGEN, Radiometer, Response Biomedical, Sepset Biosciences, Siemens Healthineers, TCS Biosciences, and Thermo Fisher Scientific.

Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is Increasing use of biomarkers for sepsis. The increased preference for biomarkers offers homogeneity of risk or disease status of the patient within limited time and provides precision diagnosis will increase its adoption rate. Biomarkers are used as diagnostic tools for the diagnosis of a disease or abnormal conditions of sepsis, including severe sepsis. The accuracy and timely detection of sepsis are regarded as the significant challenges. Therefore, the health providers rely on nonspecific clinical and laboratory signs.”

According to the report, one of the major drivers for this market is Rising prevalence of hospital acquired infection (HAIs) globally. Increasing cases of HAIs in the population is the leading cause of sepsis. HAI is also known as the nosocomial infection, which may affect the population during hospitalization or after the patient is discharged from the hospital. The presence of immunocompromised patients in hospitals, transmission of the pathogen between the staff and the patient, and the presence of microorganisms and contaminated particles in the hospital environment are the major factors that result in HAIs. The number of cases for HAIs is on the rise across the world, leading to septicemia. This drives the demand for sepsis diagnostics worldwide.

Further, the report states that one of the major factors hindering the growth of this market is High cost of sepsis treatment. The high cost of sepsis treatment is regarded as one of the market constraints, which affects the growth of the sepsis diagnostics market. Therefore, the high price of procedures decreases the adoption rate of this product, especially in the reference laboratories and small clinics where the budget allocated is very less. However, the cost-efficient treatment is likely to increase the adoption rate during the forecast period.

Companies Mentioned

bioMérieux, T2 Biosystems, Alere, Abionic, AdvanDx, Aethlon Medical, AusDiagnostics, Beckman Coulter, Beckton Dickinson, Momentum Bioscience, Bio-Rad Laboratories, Bruker, Cepheid, Curetis, CytoSorbents, Fast Track Diagnostics, F. Hoffmann-La Roche, Fujirebio Europe, Hansa Medical, Hain Lifescience, Immunexpress, Inflammatix, Merck, miacom diagnostics, Mitsubishi Chemical Europe, Nanōmix, QIAGEN, Radiometer, Response Biomedical, Sepset Biosciences, Siemens Healthineers, TCS Biosciences, and Thermo Fisher Scientific.

  • Executive summary
  • Scope of the report
  • Research methodology
  • Introduction
    • Market outline
      • Table Stages of sepsis
      • Table Products offered for severity of sepsis
  • Market landscape
    • Market overview
      • Table Market overview: Global sepsis diagnostics market 2016-2021
    • Market size and forecast
      • Table Global sepsis diagnostics market 2016-2021 ($ millions)
      • Table Reimbursement for sepsis in the US
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by technology
    • Market overview
      • Table Market overview of sepsis diagnostics by technology 2016
    • Immunoassay testing
      • Table Global sepsis diagnostics market by immunoassay testing 2016-2021 ($ millions)
    • POCT
      • Table Global sepsis diagnostics market by POCT 2016-2021 ($ millions)
    • Molecular testing
      • Table Global sepsis diagnostics market by molecular testing 2016-2021 ($ millions)
  • Market segmentation by end-user
    • Market overview
      • Table Strategic analysis: Global sepsis diagnostics market by end-users 2016
    • Hospital and clinics
    • Diagnostic laboratories
      • Table Buying criteria for global sepsis diagnostics market by end user 2016
  • Geographical segmentation
    • Table Global sepsis diagnostics market by geography in 2016 and 2021 ($ millions)
    • Sepsis diagnostics market in Americas
      • Table Market overview: Sepsis diagnostics market in Americas 2016-2021
      • Table Sepsis diagnostics market in Americas 2016-2021 ($ millions)
    • Sepsis diagnostics market in EMEA
      • Table Market overview: Sepsis diagnostics market in EMEA 2016-2021
      • Table Sepsis diagnostics market in EMEA 2016-2021 ($ millions)
    • Sepsis diagnostics market in APAC
      • Table Market overview: Sepsis diagnostics market in APAC 2016-2021
      • Table Sepsis diagnostics market in APAC 2016-2021 ($ millions)
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Market analysis: Sepsis-related to HAI
      • Table Ongoing clinical trials by NHS in the UK
    • Market challenges
  • Market trends
    • Development of novel products
    • Increasing use of biomarkers for sepsis
    • Increasing online campaigns for sepsis awareness
  • Vendor landscape
    • Competitive landscape
      • Table Competitive structure analysis of global sepsis diagnostics market 2016
      • Table Market penetration of various global sepsis diagnostics market providers 2016
      • Table Strategic success factors of companies in global sepsis diagnostics market 2016
  • Key vendors
    • bioMérieux
      • Table bioMérieux: Key highlights
      • Table bioMérieux: Strength assessment
      • Table bioMérieux: Strategy assessment
      • Table bioMérieux: Opportunity assessment
    • T2 Biosystems
      • Table T2 Biosystems: Key highlights
      • Table T2 Biosystems: Strength assessment
      • Table T2 Biosystems: Strategy assessment
      • Table T2 Biosystems: Opportunity assessment
    • Key companies to watch
      • Table Abbott: Company assessment
      • Table Nanosphere: Company assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report